Trillium Therapeutic (TRIL) Stock Analyst Ratings
NASDAQ:TRIL - Nasdaq -
ChartMill assigns a Buy % Consensus number of 78% to TRIL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 15.2. This target is -17.59% below the current price.
TRIL was analyzed by 10 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about TRIL.
In the previous month the buy percentage consensus was at a similar level.
TRIL was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-11-17 | Benchmark | Downgrade | Buy -> Hold |
| 2021-08-24 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2021-08-24 | Craig-Hallum | Downgrade | Buy -> Hold |
| 2021-08-23 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |